Literature DB >> 23821142

Aging, age-related diseases and peroxisomes.

Marc Fransen1, Marcus Nordgren, Bo Wang, Oksana Apanasets, Paul P Van Veldhoven.   

Abstract

Human aging is considered as one of the biggest risk factors for the development of multiple diseases such as cancer, type-2 diabetes, and neurodegeneration. In addition, it is widely accepted that these age-related diseases result from a combination of various genetic, lifestyle, and environmental factors. As biological aging is a complex and multifactorial phenomenon, the molecular mechanisms underlying disease initiation and progression are not yet fully understood. However, a significant amount of evidence supports the theory that oxidative stress may act as a primary etiologic factor. Indeed, many signaling components like kinases, phosphatases, and transcription factors are exquisitely sensitive to the cellular redox status, and a chronic or severe disturbance in redox homeostasis can promote cell proliferation or trigger cell death. Now, almost 50 years after their discovery, there is a wealth of evidence that peroxisomes can function as a subcellular source, sink, or target of reactive oxygen and nitrogen molecules. Yet, the possibility that these organelles may act as a signaling platform for a variety of age-related processes has so far been underestimated and largely neglected. In this review, we will critically discuss the possible role of peroxisomes in the human aging process in light of the available data.

Entities:  

Mesh:

Year:  2013        PMID: 23821142     DOI: 10.1007/978-94-007-6889-5_3

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  30 in total

1.  Pex35 is a regulator of peroxisome abundance.

Authors:  Ido Yofe; Kareem Soliman; Silvia G Chuartzman; Bruce Morgan; Uri Weill; Eden Yifrach; Tobias P Dick; Sara J Cooper; Christer S Ejsing; Maya Schuldiner; Einat Zalckvar; Sven Thoms
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

Review 2.  Pexophagy in yeast and mammals: an update on mysteries.

Authors:  Tanja Eberhart; Werner J Kovacs
Journal:  Histochem Cell Biol       Date:  2018-09-21       Impact factor: 4.304

Review 3.  A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.

Authors:  Ayumu Sugiura; Gian-Luca McLelland; Edward A Fon; Heidi M McBride
Journal:  EMBO J       Date:  2014-08-08       Impact factor: 11.598

4.  Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress.

Authors:  Lingjuan Piao; Debra Dorotea; Songling Jiang; Eun Hee Koh; Goo Taeg Oh; Hunjoo Ha
Journal:  Antioxid Redox Signal       Date:  2019-12-20       Impact factor: 8.401

Review 5.  Peroxisome deficient invertebrate and vertebrate animal models.

Authors:  Paul P Van Veldhoven; Myriam Baes
Journal:  Front Physiol       Date:  2013-11-22       Impact factor: 4.566

6.  Peroxisomes proliferation and pharmacological stimulation of autophagy in rat liver: evidence to support that autophagy may remove the "older" peroxisomes.

Authors:  Gabriella Cavallini; Alessio Donati; Michele Taddei; Ettore Bergamini
Journal:  Mol Cell Biochem       Date:  2017-03-02       Impact factor: 3.396

Review 7.  Peroxisomes and Kidney Injury.

Authors:  Radovan Vasko
Journal:  Antioxid Redox Signal       Date:  2016-04-22       Impact factor: 8.401

Review 8.  The crucial impact of lysosomes in aging and longevity.

Authors:  Didac Carmona-Gutierrez; Adam L Hughes; Frank Madeo; Christoph Ruckenstuhl
Journal:  Ageing Res Rev       Date:  2016-04-26       Impact factor: 10.895

Review 9.  Peroxisome-mitochondria interplay and disease.

Authors:  Michael Schrader; Joseph Costello; Luis F Godinho; Markus Islinger
Journal:  J Inherit Metab Dis       Date:  2015-02-17       Impact factor: 4.982

10.  Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.

Authors:  Pol Andrés-Benito; Ellen Gelpi; Mariona Jové; Natalia Mota-Martorell; Èlia Obis; Manuel Portero-Otin; Mònica Povedano; Aurora Pujol; Reinald Pamplona; Isidro Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.